Kristina Jankovic, MD· @JankovicK · X·· 3 天前评分70
正文 · 机器翻译
令人鼓舞的 6 年期 #NATALEE 研究结果在 #ESMO26 上公布！🎯
辅助治疗 ribociclib + NSAI 在 HR+/HER2− 早期 #BreastCancer 中显示出持续扩大的 iDFS 获益和良好的 OS 结果
@OncoAlert
353 浏览 · 5 赞 · 4 转发 · 0 回复
会议摘要
LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgOral abstract #BreastCancer session at #ESMO26: updated data from NATALEE trial simultaneously published in @Annals_Oncology @OncoAlert @myESMO在 X 查看被引用的帖子
来源：Kristina Jankovic, MD · x.com